Database analyses performed to reveal the prognostic role of ADAM32 in other types of cancer (by using the Kaplan–Meier plot) showed that higher expression of ADAM32 is correlated with poorer prognosis in breast, ovarian, lung, and gastric cancers, whereas it is correlated with better prognosis in HCC (Figure S5a–f). Here, ADAM32 is linked to hepatocellular carcinoma.